Skip to main content
. Author manuscript; available in PMC: 2014 Aug 18.
Published in final edited form as: Thorax. 2011 Nov 16;67(4):309–314. doi: 10.1136/thoraxjnl-2011-200702

Table 1.

Clinical and demographic characteristics of study participants

OLD absent OLD present p Value
N 901 176
Age, years 47.7 (7.76) 49.6 (8.88) 0.004
Male, n (%) 586 (65) 118 (67) 0.61
Black race, n (%) 805 (89) 149 (85) 0.07
BMI, kg/m2 25.7 (22.7–30.1) 23.9 (21.5–28.1) <0.001
Smoking status, n (%)
    Current 769 (85) 155 (88) 0.55
    Former 84 (9) 15 (9)
    Never 47 (5) 6 (3)
Smoking, pack-years 20 (12–33) 22 (14–39) 0.02
FEV1
    Absolute (I) 2.92 (0.74) 2.26 (0.82) <0.001
    % Predicted 95.7 (15.4) 71.7 (18.8) <0.001
FVC (I) 3.70 (0.96) 3.57 (1.15) 0.11
FEV1/FVC ratio 0.79 (0.05) 0.63 (0.07) <0.001
Ever smoked cocaine or heroin, n (%) 643 (72) 126 (72) 0.99
Hepatitis C antibody-positive, n (%) 754 (84) 149 (85) 0.75
Current IDU, n (%)*
None 523 (58) 105 (60) 0.17
    <1 injection/day 221 (25) 33 (19)
    ≥1 injection/day 157 (17) 38 (22)

Values presented as mean (SD) or median (IQR) unless indicated otherwise.

*

In previous 6 months.

BMI, body mass index;FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; IDU, injection drug use; OLD, obstructive lung disease; pack-years, number of packs smoked per day × years smoked.